Dec 23, 2025 09:18AM BMO Capital on Novo Nordisk (NVO): 'FDA Approval Brings Much-Needed Cheer'

Dec 18, 2025 10:07AM BMO Capital Reiterates Outperform Rating on Eli Lilly (LLY)

Nov 25, 2025 04:26AM Novo Nordisk (NVO) PT Lowered to $46 at BMO Capital

Nov 17, 2025 08:14AM BMO Capital: 'Extraordinary General Meeting Sets the Stage for Novo Nordisk (NVO) Transformation'

Nov 12, 2025 03:08PM Analysis-Novo Nordisk CEO signals new appetite for risk in obesity deals

Nov 5, 2025 05:05PM Novo Nordisk (NVO) PT Lowered to $50 at BMO Capital

Oct 30, 2025 08:47AM Novo Nodrisk stock dips on aggressive odder to buy Metsera, 'reckless' says Pfizer

Oct 24, 2025 08:31AM Novo Nordisk's new chairman has 'carte blanche' after board clear-out

Oct 14, 2025 04:57AM Novo Nordisk (NVO) PT Raised to $55 at BMO Capital

Oct 9, 2025 06:17AM Novo to buy Akero for up to $5.2 billion in new CEO's revival push

Sep 18, 2025 10:19AM BMO Capital on Novo Nordisk (NVO): 'still give the competitive edge to Lilly following this week'

Sep 10, 2025 08:54AM BMO Capital on Novo Nordisk (NVO): 'New CEO Doustdar Implements Massive Restructuring'

Aug 18, 2025 06:49AM BMO Capital: 'Novo Nordisk (NVO) Takes a Step in the Right Direction'

Aug 7, 2025 07:53AM Novo Nordisk (NVO) PT Lowered to $50 at BMO Capital

Aug 1, 2025 04:30AM European drugmakers fall after Trump raises stakes over US drug price cuts

Jul 29, 2025 04:36PM Novo Nordisk (NVO) PT Lowered to $55 at BMO Capital

Jul 1, 2025 06:06AM How Novo Nordisk misread the US market for its weight loss sensation

May 19, 2025 08:32AM BMO Capital on Novo Nordisk (NVO): 'CEO Switch Up Highlights Recent Novo Pressures'

May 14, 2025 08:22AM BMO Capital Reiterates Market Perform Rating on Novo Nordisk (NVO)

Apr 17, 2025 06:56AM Lilly weight-loss pill works as well as Ozempic, shares surge

Apr 17, 2025 05:11AM BMO Capital Downgrades Novo Nordisk (NVO) to Market Perform

Apr 9, 2025 09:19AM Pharma stocks slide after Trump signals tariffs on sector

Mar 25, 2025 09:06AM BMO Capital Reiterates Outperform Rating on Novo Nordisk (NVO)

Mar 24, 2025 08:20AM Novo bets on 'triple G' obesity drug in up to $2 billion deal with Chinese biotech

Jan 28, 2025 04:59PM BMO Capital Reiterates Outperform Rating on Novo Nordisk (NVO) following latest Ozempic approval

Jan 24, 2025 09:09AM BMO Capital Reiterates Outperform Rating on Novo Nordisk (NVO) Amid Solid SubQ Amycretin Results

Jan 17, 2025 02:29PM Explainer-What Wegovy's inclusion in Medicare price negotiation means for patients, company

Dec 23, 2024 08:22AM Novo Nordisk (NVO) PT Lowered to $105 at BMO Capital

Dec 20, 2024 02:12PM Novo Nordisk (NVO) PT Lowered to $105 at BMO Capital

Dec 19, 2024 08:03PM In weight loss battle, Novo and Lilly face growing offensive from licensed copies

Dec 4, 2024 08:50AM BMO Capital: Five Key BioPharma Catalysts Through Year-End '24

Dec 2, 2024 02:46PM Lilly Products Show Strength Heading Into the Holiday

Nov 22, 2024 02:06PM BMO Capital Reiterates Outperform Rating on Novo Nordisk (NVO)

Nov 18, 2024 02:10PM BMO Capital Reiterates Outperform Rating on Eli Lilly (LLY)

Sep 23, 2024 07:35AM BMO Capital Reiterates Outperform Rating on Novo Nordisk (NVO)

Sep 20, 2024 09:56AM Monlunabant early obesity data not a key driver for Novo Nordisk (NVO) - BMO

Sep 11, 2024 08:32AM BMO Capital on Novo Nordisk (NVO): 'given that Amycretin is a peptide we would like to hear more from Novo on manufacturing, a potential point of differentiation for the small molecule assets'

Aug 8, 2024 09:14AM Novo Nordisk (NVO) PT Lowered to $160 at BMO Capital

Jun 25, 2024 07:51AM BMO Capital Reiterates Outperform Rating on Novo Nordisk (NVO)

May 28, 2024 06:18AM Analysis-Weight-loss drug forecasts jump to $150 billion as supply grows

May 2, 2024 06:23AM Novo Nordisk (NVO) sales jump on strong demand for obesity drug

Apr 12, 2024 12:53PM BMO Capital starts Novo Nordisk (NVO) at Outperform

Apr 12, 2024 04:05AM BMO Capital Starts Novo Nordisk (NVO) at Outperform

Oct 4, 2018 09:51AM Lilly's diabetes drug data impresses, hurts rival Novo's shares